Description

1,3-Dioxolo[4,5-G]Quinazolin-8(7H)-One, 7-Amino-6-(2-Furyl)-4-Methoxy- (6Ci) is a high-purity, complex heterocyclic compound featuring a fused quinazolinone and dioxole structure. This molecule is valued as a key synthetic intermediate and a versatile scaffold for advanced research and development in medicinal chemistry. It is primarily sought by pharmaceutical R&D teams and fine chemical manufacturers engaged in developing novel therapeutic agents and high-value specialty chemicals.

Application

• Pharmaceutical Intermediate: Serves as a critical building block for the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, oncology, and anti-inflammatory pathways.
• Medicinal Chemistry Research: Used as a core scaffold in structure-activity relationship (SAR) studies and combinatorial chemistry libraries to explore new bioactive molecules.
• Organic Synthesis Reagent: Employed in advanced organic synthesis for constructing complex fused heterocyclic systems due to its reactive amino and furyl functional groups.
• Biochemical Research: Potential use as a tool compound or probe in biochemical assays to study enzyme inhibition or receptor binding mechanisms.
• Fine Chemical Production: Acts as a precursor in the multi-step synthesis of specialty chemicals, dyes, and advanced materials requiring specific heterocyclic architectures.

Basic Information

Product Name	1,3-Dioxolo[4,5-G]Quinazolin-8(7H)-One, 7-Amino-6-(2-Furyl)-4-Methoxy- (6Ci)
CAS No.	108760-05-0
Molecular Formula	C₁₄H₁₁N₃O₄
Molecular Weight	285.26 g/mol
Synonyms	7-Amino-6-(2-furyl)-4-methoxy-[1,3]dioxolo[4,5-g]quinazolin-8(7H)-one; 6-(2-Furanyl)-7-amino-4-methoxy-[1,3]dioxolo[4,5-g]quinazolin-8(7H)-one; 7-Amino-6-(furan-2-yl)-4-methoxy-[1,3]dioxolo[4,5-g]quinazolin-8-one; 108760-05-0; 6Ci compound; Fused quinazolinone derivative; Amino-furyl-methoxy dioxoloquinazolinone
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management protocols. Every batch undergoes comprehensive analytical characterization using techniques such as HPLC, NMR, and MS to ensure identity, purity, and consistency. We provide a detailed Certificate of Analysis (COA) with each shipment, documenting all critical quality attributes. Our commitment to cGMP-compliant practices where applicable ensures the material meets the stringent requirements of pharmaceutical and research applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability. Keep container tightly sealed when not in use to protect from moisture.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.